We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
1 Study found for: GSK525762 in subjects with relapsed, refractory hematologic malignancies

Terms and Synonyms Searched:

Terms Search Results* Entire Database**
Synonyms
GSK525762 in subjects with relapsed, refractory hematologic malignancies 1 studies 1 studies
refractory hematologic malignancies 1 studies 67 studies
Refractory Hematologic Cancer -- 13 studies
malignancies 1 studies 66,067 studies
Oncology 1 studies 11,310 studies
Tumor 1 studies 29,282 studies
Cancer 1 studies 52,631 studies
Malignant Growth -- 2 studies
Neoplasia -- 762 studies
Neoplasm -- 52,834 studies
Neoplastic Disease -- 51 studies
neoplastic growth -- 2 studies
neoplastic syndrome -- 503 studies
hematologic 1 studies 14,555 studies
Haematologic -- 28 studies
hematology -- 6,109 studies
refractory 1 studies 8,221 studies
Intractable -- 270 studies
Unresponsive -- 208 studies
relapsed 1 studies 10,205 studies
Relapse -- 5,906 studies
relapsing -- 1,267 studies
subjects 1 studies 61,972 studies
Study Participant -- 2,058 studies
GSK525762 1 studies 6 studies

   
-- No studies found
* Number of studies in the search results containing the term or synonym
** Number of studies in the entire database containing the term or synonym